UBS analyst Sanjeet Aujla lowered the firm’s price target on AB InBev (BUD) to EUR 66 from EUR 70 and keeps a Buy rating on the shares as part of a Q4 earnings preview. The company’s volumes are still weak, but its leverage and free cash flow will “positively inflect,” the analyst tells investors in a research note. The firm believes AB InBev’s deleveraging and free cash flow upside is on track despite a soft volume quarter.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BUD:
- Why Investors Should Buy Diageo Stock (DEO) on the Dip
- AB InBev price target lowered to $55 from $65 at TD Cowen
- Drink makers drop as Surgeon General proposes cancer warning on alcohol
- Surgeon General issues new advisory on link between alcohol and cancer risk
- Anheuser-Busch InBev (BUD) Loses Control of Its Russian Joint Venture